Renaissance Technologies - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 138 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$75
+97.4%
358,200
+52.4%
0.00%
Q1 2023$38
-83.7%
235,000
-44.0%
0.00%
Q4 2022$233
-100.0%
419,600
-37.4%
0.00%
-100.0%
Q3 2022$798,000
+65.9%
670,612
-11.9%
0.00%0.0%
Q2 2022$481,000
-56.0%
761,164
-20.5%
0.00%0.0%
Q1 2022$1,092,000
+32.5%
957,460
+161.3%
0.00%0.0%
Q4 2021$824,000
+387.6%
366,395
+641.7%
0.00%
Q3 2021$169,000
-92.1%
49,400
-93.1%
0.00%
-100.0%
Q2 2021$2,151,000
-41.4%
719,367
-36.7%
0.00%
-40.0%
Q1 2021$3,669,000
-21.9%
1,136,067
-48.7%
0.01%0.0%
Q4 2020$4,698,000
+124.7%
2,215,974
+24.0%
0.01%
+150.0%
Q3 2020$2,091,000
+41.8%
1,786,933
+9.6%
0.00%
+100.0%
Q2 2020$1,475,000
+27.0%
1,630,638
+17.7%
0.00%0.0%
Q1 2020$1,161,000
-3.9%
1,385,414
+10.1%
0.00%0.0%
Q4 2019$1,208,000
+4.6%
1,258,313
+12.3%
0.00%0.0%
Q3 2019$1,155,000
-36.0%
1,120,940
+11.9%
0.00%
-50.0%
Q2 2019$1,804,000
+7.7%
1,002,006
+12.4%
0.00%0.0%
Q1 2019$1,675,000
+72.7%
891,200
+8.4%
0.00%
+100.0%
Q4 2018$970,000
-51.4%
821,900
+11.6%
0.00%
-50.0%
Q3 2018$1,996,000
-10.5%
736,700
-33.6%
0.00%
+100.0%
Q2 2018$2,229,000
+87.0%
1,110,200
+95.6%
0.00%0.0%
Q1 2018$1,192,000
-18.2%
567,500
-20.9%
0.00%
-50.0%
Q4 2017$1,457,000
-31.9%
717,900
-55.4%
0.00%
-33.3%
Q3 2017$2,141,000
+16.5%
1,610,000
+37.6%
0.00%
+50.0%
Q2 2017$1,837,000
-60.5%
1,169,873
-18.7%
0.00%
-66.7%
Q1 2017$4,649,000
+102.6%
1,439,241
-15.3%
0.01%
+50.0%
Q4 2016$2,295,000
-20.9%
1,700,000
-8.6%
0.00%
-20.0%
Q3 2016$2,903,000
+191.2%
1,860,900
+148.2%
0.01%
+150.0%
Q2 2016$997,000
+1433.8%
749,700
+5995.1%
0.00%
Q1 2016$65,000
-94.8%
12,300
-92.2%
0.00%
-100.0%
Q4 2015$1,241,000
-83.3%
158,100
-82.0%
0.00%
-83.3%
Q3 2015$7,415,000
-43.5%
877,500
-26.8%
0.02%
-40.0%
Q2 2015$13,122,000
+40.5%
1,198,350
+79.4%
0.03%
+50.0%
Q1 2015$9,339,000
+174.3%
668,000
+231.3%
0.02%
+150.0%
Q4 2014$3,405,000
+493.2%
201,600
+371.0%
0.01%
+300.0%
Q3 2014$574,000
-77.3%
42,800
-78.4%
0.00%
-66.7%
Q2 2014$2,530,000
-57.3%
198,600
-60.2%
0.01%
-57.1%
Q1 2014$5,928,000
-43.8%
498,540
-34.7%
0.01%
-44.0%
Q4 2013$10,545,000
+191.5%
763,600
+267.8%
0.02%
+177.8%
Q3 2013$3,618,000
-12.9%
207,600
-19.1%
0.01%
-18.2%
Q2 2013$4,156,000256,7000.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Highlander Capital Management, LLC 3,500$00.00%
Steward Partners Investment Advisory, LLC 100$20.00%
XTX Topco Ltd 181,068$2,8970.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders